Sundhed fra nyhedsbrev 39

Nedenstående profiler er publiceret i det nyhedsbrev, der er udsendt til medlemmer af Virksomhedsforum.

Hvis du har yderlige spørgsmål til dem, eller du ønsker at få din egen profil publiceret i hele verden, kontakt da Henrik Sørensen på hso@aalborg.dk eller 9931 1539

10 GB 41n8 3G61
A handheld infrared thermometer that helps combat Legionnaires disease
A UK company offers a non-contact thermometer that measures the temperature of metal pipes, plastic storage vessels etc without touching them - to make sure they are within an acceptable temperature range to limit the growth of this deadly bacteria. With hundreds already being used in UK public buildings, the easy to operate thermometers have a built in laser pointer so there is no guesswork in where the instrument is aimed. The company is seeking additional industrial/commercial partners.

09 GB 46P4 3FU2
Protein Kinase Profiling Service for Drug Target Evaluation
A world renowned Protein Kinase Profiling Service based in Dundee Scotland is seeking partners from the Biotechnology and Pharmaceutical industry developing new treatments for major diseases to test/trial their Kinase profiling service as part of their drug target evaluation. Partnerships for Technical co-operation and commercial partnerships are sought.

09 GB 46P4 3FU4
Unique Screening Model for the negative symptoms and cognitive deficits of schizophrenia
This Scottish based group offers a unique well established and validated screening model of schizophrenia to partners developing potential drugs for the negative symptoms and cognitive deficits of schizophrenia. They are seeking partners from Industry and Academic for technical and commercial collaborations.

09 GB 41n8 3FQZ
Affordable off the shelf laboratory scale continuous flow reactors
Emergence of continuous flow chemistry on laboratory scale has been hampered by cost and availability of equipment. A UK company proposes a flexible range of reactor systems with off the shelf designs, based on several years of development in the field and feedback from many customers. Now the value added from switching to continuous chemistry greatly outweighs the cost. Chemical research laboratories are sought for commercial agreements with technical assistance and adaptation to specific needs

09 IS 81ET 3FQR
In vivo research methods
An Icelandic biotechnological company is specialized in the field of Pharmacology and drug discovery. The company offers an array of in vivo research to support the partner lead optimization efforts.  These are, amongst others, in the field of toxicology and pharmacokinetics.  The company is looking for Pharmaceutical companies, universities and research institutes for Technical Co-operation and Commercial Agreement with Technical Assistance.

09 GB 39n3 3F9D
A Hand Held Asthma Drug Dosage Monitor with Improved Patient Compliance and Dosing Accuracy
A UK University Research Team has developed a hand held monitoring device that will enable patients to measure the level of asthma medication (in vapour form) being inhaled during the administration process via visual indication. Thus decreasing patient error and increasing the likelihood of the patient receiving appropriate levels of medication. A licensing or technical cooperation agreement is sought.

09 GB 39n3 3F9G
Predictive Markers of Pre-Diabetes and Type 2 Diabetes
Research at a UK University has yielded the discovery and preclinical development of two optimized, specific immunoassays which function by quantifying naturally occurring glycated peptides found to be elevated in newly diagnosed diabetics as well as those patients predisposed to developing the disease. The group is seeking a strategic partner for further development and provision of a route to market for using the technology in the detection of pre-diabetes and type II diabetes.

09 GB 39n3 3F9C
A Toxin Independent Biomarker for the Detection of Clostridium difficile
UK University Researchers have developed a unique method for C. difficile testing which can be utilized for the development of a highly sensitive diagnostic test for the rapid, low cost, routine screening of CDI in healthcare settings. A licensing or technical cooperation agreement is sought.

10 EE 21B9 3G4T
PS  PECS -  project Heart and Blood Circulation Holter Device
An Estonian SME and coordinator of a consortia is looking for partner(s) for further developing and industrialization of a specific device for measuring and monitoring of heart rate and blood pressure related parameters of:
1. cardiovascular patients
2. athletes
3. astronauts in the micro-gravity environment
Partners with the involvement in European Space Agency (ESA) programs are highly expected since planned project can be executed under Program of European Cooperating States (PECS).

09 ES 28G2 3G0W
New vaccines against animal brucellosis and associated diagnostic methods
A Spanish public research organization has developed a genetically modified vaccine against animal brucellosis that expresses the fluorescent protein GFP. The genetic modification does not alter the vaccine s biological properties. Vaccinated animals can be identified by ELISA quantification of anti-GFP antibodies present in animal sera, and by UV detection, fluorescence microscopy or PCR. Partners from the veterinarian industry are sought for licence agreement.

09 ES 28G2 3DX8
Peptidic tag to promote cellular degradation of proteins
A Spanish public research organisation has developed a peptidic tag that promotes the endo-lysosomal degradation of proteins fused to it. This feature could be used to look for drugs that inhibit protein post-translational modifications, useful for treatment of cancer, progeria and for inhibition of cholesterol synthesis. Cell biology assays and assays in organisms can be used for drug screening. Companies interested in the technology are sought for exploitation under a patent licence agreement.

09 ES 28G2 3G0F
Cannabinoids for treatment of neurodegenerative diseases and diseases related to neurotransmission
A Spanish public research organisation has developed indazolyl ethers with cannabinoid properties and involved in the metabolism of neurotransmitters. These compounds can be used to treat diseases that affect the cannabinoid system and neurotransmission, such as Alzheimer, Huntington and multiple sclerosis. Partners from the pharmaceutical industry are sought for exploitation under a patent licence agreement.

09 GR 49R2 3FX8
Drug repositioning, adverse event profiling and clinical hold services on offer
A Greek drug repositioning company is offering drug profiling services to biotechnology and pharmaceutical companies. The services cover drug repositioning opportunities, adverse event profiling as well as support in clinical hold and related situations. The services are offered to partner companies who are assessing their own drug pipeline as well as in-licensing opportunities.

09 ES 25E2 3FW6
Genotyping to perform and develop custom-made genetic analysis
A Catalan technology laboratory (Spain) has developed its own genetic tests in the field of pharmacogenomics. They are offering their analysis for developing and performing custom-made genetic analysis. The technology used in their genotyping platform is designed for speed and high-throughput, ensuring that results are obtained as fast as it is currently possible. They are looking for an industrial or research partner to join further development or for a manufacturing agreement.

09 NL 60AH 3D6F
Extraction technology for higher purity of Ginkgo Terpene
A Dutch SME has developed a technology for the extraction and refining of effective components of Ginkgo leaves. The extracts can be used in pharmaceutical and cosmetic products and as nutrient components. The company is looking for a partner with knowledge of extracting technology to further improve the production process and/or companies that are interested in producing extracts with the new extracting technology.

09 NL 60AH 3FK7
Innovative technologies for the obstetrics gynaecology and fertility market
A Dutch company is specialized in valorization and commercialization of pharmaceutical products in the field of obstetrics gynaecology and fertility. The main expertise is focussed on testing, implementation and product development. For implementation and the review of new technologies the company makes use of a broad network of gynaecologists in the Netherlands. The company is interested  in in-licencing existing and phase III biotechnology related products.

09 RU 86FG 3FYA
Collection of genome DNA samples for analysis of coronary heart disease (CHD) genetic predictors prevalence among population and CHD patients
A Russian company from Moscow, making research in the field of genetic predictors of cardiovascular diseases, owns a collection of genomic DNA samples from patients with coronary heart disease (~ 500) and healthy donors (~ 700). The company seeks technical cooperation partners with expertise of methods in the field of PCR (polymerase chain reaction) detection of genomic predictors related to development or complication of coronary heart disease.